Janus Research Fund (JAMRX)

Large-Cap Growth Utilizing Our Analysts' Best Ideas


Janus & Henderson: Recommended Merger of Equals. To learn more read the press release.


Inception Date5/3/1993
NAV (As of 10/21/16)$42.08
Total Net Assets (As of 9/30/16)$4.53B
Annual Expense Ratio
(As of fiscal year end 9/30/15)
GROSS 1.00%
NET 1.00%

Performance (As of 9/30/16)
1 Year9.38%
3 Year11.22%
5 Year16.13%
10 Year9.01%
Morningstar (As of 9/30/16)
CategoryLarge Growth
Overall Rating™
(Based on risk-adjusted returns)

View All Ratings

1482 Funds Rated
Style Box

Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold. For the most recent month-end performance click here.

Returns greater than one year are annualized.

Quarterly Commentary - Q3 2016


U.S. stocks rose during the quarter, led largely by cyclical sectors.

The Fund underperformed its benchmark, weighed down by its consumer and technology holdings.

We view innovation as a driver of earnings, not only in technology and health care, but also in other sectors, including consumer and financials.